Olaf Michaelsen
Director Access Reimbursement Economics Assessment Emea @Oncosil Medical
Signup · Get unlimited contacts
WORK HISTORY
Director Access Reimbursement Economics Assessment Emea @Oncosil Medical
KEY ACHIEVEMENT Successful evidence dossier-based application to the German Federal Joint Committee (GBA) for temporary coverage while generating randomised clinical evidence funded by health insurance companies (coverage with clinical evidence development; CED) – capitalised value of €1.75m –. The CED study is currently prepared by an independent scientific research institute on behalf of the GBA and should start to enrol patients by mid of 2026. • Leading the development of innovation funding (NUB) requests through German hospitals to Institute for calculation of inpatient hospital reimbursement (InEK).• Leading the development of reimbursement dossier incl. Budget-Impact-Analysis (BIA) on ultrasound-guided endoscopic injection implantation of ³²P-labelled microparticles combined with systemic chemotherapy in treatment of primarily unresectable locally advanced pancreatic tumours and submission to Belgian HTA agency NIHDI.• Exploring the French CED \"forfait innovation\" scheme in collaboration with KOLs and relevant medical societies for submission to HTA agency HAS.• Leading the preparation of interventional procedure guidance application to English HTA agency NICE.• Exploring the HTA & CEA-based public health insurance market access scheme conducted by Dutch ZIN Agency with particular consideration of the CED \"potentially promising care\" scheme as well as the diagnosis-related groups (DRG) based hospital reimbursement in the Netherlands. • Supporting the development of a reimbursement dossier to be submitted to the Greek Ministry of Health (MoH) through a local distributor.• Supporting the development of a reimbursement dossier incl. BIA to be submitted to the Israelian MoH through a local distributor.
EDUCATION
Apollon University of applied Sciences Bremen Germany
Bachelor of Arts (B.A.), Health Economics
Technical University Berlin Germany
Certificate, Health Techology Assessment
SKILLS
ABOUT OLAF MICHAELSEN
Holistic expert in Market Access / Provider Reimbursement / Health Economics / Technology Assessment in Europe (mainly Germany / Austria / Switzerland):25 years of strategic guidance & tactical execution at local, regional, national & supranational level in implantable Medical Devices for Hospitals & and Office-based Physicians.Achievements- 1 coverage with clinical evidence development (CED) study by federal joint committee (GBA) in Germany- 487 entitlements (NUB) for applying hospitals to negotiate NUB supplementary fees with health insurance companies for inpatient procedures in Germany- 152 additional procedure codes (OPS) for inpatient procedures in Germany- 6 additional diagnosis codes (ICD) for inpatient procedures in Germany- 1 additional diagnosis-related group fees (DRG) for inpatient procedures in Germany- 17 additional supplementary fees (ZE) for inpatient procedures in Germany- 12 additional procedure codes (EBM) for outpatient procedures in Germany- 12 additional procedure codes (AOP) for outpatient surgical procedures in Germany.Product Sales / Customer & Referral Acquisition / Technical Consultancy:6 years of successful operations in Medical Devices (Implantables) for Hospitals & Office-based Physicians in- & outpatiently in Germany.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.